Breaking Down Barriers to ‘Living Medicines:’ California’s New Plan to Partner with Industry to Manufacture ‘Transformative’ Treatments

CIRM graphic

One ambitious and major objective of the California stem cell agency over the next five years is to create a “public-private manufacturing partnership network” that would remove current barriers to bringing actual treatments to large numbers of patients.

The agency’s strategic plan does not have a timetable for the effort nor does it indicate…